Abstract
Background The average concentration of fine particulate matter (PM2.5) has decreased in the U.S. in recent years. However, the health benefits of this improvement among different racial/ethnic groups are not known. This study aimed to estimate the associations between long-term exposure to ambient PM2.5 and cause-specific cardiovascular disease (CVD) mortality rate and assess the PM2.5-attributable CVD deaths in non-Hispanic White, non-Hispanic Black, and Hispanic people across all counties in the contiguous U.S. from 2001 to 2016.
Methods Using nationwide CVD mortality data for all ages obtained from National Center for Health Statistics, this study applied interactive fixed effects models to estimate the associations between 12-month moving average of PM2.5 concentrations and monthly age-adjusted CVD mortality rates by race/ethnicity, controlling for both measured and unmeasured spatiotemporal confounders. Mortality from major types of CVD (ischemic heart disease [IHD], myocardial infarction [MI], stroke, hypertensive disease, and hypertensive heart disease) was also studied. We then calculated the burden of PM2.5-attributable CVD deaths in different race/ethnicity groups and examined the magnitude of racial/ethnic disparity and its changes over time.
Results A total of 13,289,147 CVD deaths were included in the study. Each 1-µg/m3 increase in 12-month moving average of PM2.5 concentration was associated with increases of 7.16 (95% confidence interval [CI]: 3.81, 10.51) CVD deaths per 1,000,000 Black people per month, significantly higher than the estimates for non-Hispanic White people (P value: 0.002). The higher vulnerability in non-Hispanic Black people was also observed for mortality from IHD, MI, and stroke. Long-term PM2.5 exposure contributed to approximately 75.47 (95% CI: 40.14, 110.80) CVD deaths per 1,000,000 non-Hispanic Black people annually, over 3 times higher than the estimated rate in non-Hispanic White people (16.89, 95% CI:13.17, 20.62). From 2001 to 2016, the difference in attributable CVD mortality rate between Black and White people reduced by 44.04% (from 75.80 to 42.42 per 1,000,000 people), but the burden in Black people was still over 3 times higher compared to White people.
Conclusions Non-Hispanic Black people have the highest PM2.5-attributable CVD mortality burden. Although the racial/ethnic disparity in this burden was narrowed over time, the gap between racial/ethnic minorities and non-Hispanic White people remains substantial.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Dr.Zang received support from the National Institute on Aging (R21AG074238-01), the National Institute on Minority Health and Health Disparities (1R01MD017298-01), the Research Education Core of the Claude D. Pepper Older Americans Independence Center at Yale School of Medicine (P30AG021342), and the Institution for Social and Policy Studies at Yale University. Dr. Opara received support from the National Institutes on Health Director Early Independence Award (DP5OD029636; PI: Ijeoma Opara).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Using anonymized monthly county-level mortality records, this study was determined as a Not Human Subject research and approved by the Yale Institutional Review Boards (protocol ID: 2000026808).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Air pollution data are available online at the NASA Socioeconomic Data and Applications Center (https://sedac.ciesin.columbia.edu/data/set/aqdh-pm2-5-concentrations-contiguous-us-1-km-2000-2016). Air temperature are available online at the PRISM Climate Group (https://prism.oregonstate.edu/). County-level population data are available online from the Surveillance, Epidemiology, and End Results Program, National Cancer Institute. Monthly mortality data from the National Center for Health Statistics are not publicly available.
